Breaking News, Collaborations & Alliances

ZeClinics Moves Headquarters to Almirall R&D Centre

ZeClinics will leverage Almirall's state-of-the-art technology facilities to accelerate drug discovery by providing high-throughput safety and efficacy screenings.

Almirall, a global biopharmaceutical company focused on skin health, entered into an agreement with ZeClinics, a Contract Research Organization (CRO) specialized in zebrafish, to be based at Almirall’s R&D centre. Through the agreement, Almirall aims to transform its R&D centre in Sant Feliu de Llobregat, Spain, into a uniquely collaborative environment where researchers from biotech companies, start-ups, academia, and other scientist meet with Almirall’s team to enhance researc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters